Glaukos Drug Patent Portfolio
Glaukos owns 1 orange book drug protected by 4 US patents Given below is the list of Glaukos's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12201555 | Drug eluting ocular implant | 14 Feb, 2031 | Active |
| US10206813 | Implants with controlled drug delivery features and methods of using same | 17 Oct, 2030 | Active |
| US11426306 | Implants with controlled drug delivery features and methods of using same | 17 Oct, 2030 | Active |
| US12201557 | Drug eluting ocular implant and method of treating an ocular disorder | 18 Jun, 2030 | Active |
Latest Legal Activities on Glaukos's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Glaukos.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 30 Aug, 2022 | US11426306 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 30 Aug, 2022 | US11426306 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Aug, 2022 | US10206813 |
|
Email Notification
Critical
| 11 Aug, 2022 | US11426306 |
|
Issue Notification Mailed
Critical
| 10 Aug, 2022 | US11426306 |
| Dispatch to FDC | 29 Jul, 2022 | US11426306 |
| Workflow - Drawings Finished | 28 Jul, 2022 | US11426306 |
| Mail PUB other miscellaneous communication to applicant | 03 Jun, 2022 | US11426306 |
|
Email Notification
Critical
| 03 Jun, 2022 | US11426306 |
| PUB Other miscellaneous communication to applicant | 01 Jun, 2022 | US11426306 |
|
Application Is Considered Ready for Issue
Critical
| 06 May, 2022 | US11426306 |
| Dispatch to FDC | 06 May, 2022 | US11426306 |
|
Issue Fee Payment Received
Critical
| 05 May, 2022 | US11426306 |
|
Issue Fee Payment Verified
Critical
| 05 May, 2022 | US11426306 |
| Response to Reasons for Allowance | 05 May, 2022 | US11426306 |
Glaukos's Family Patents
Glaukos Drug List
Given below is the complete list of Glaukos's drugs and the patents protecting them.
1. Idose Tr
Idose Tr is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12201555 | Drug eluting ocular implant |
14 Feb, 2031
(5 years from now)
| Active |
| US10206813 | Implants with controlled drug delivery features and methods of using same |
17 Oct, 2030
(5 years from now)
| Active |
| US11426306 | Implants with controlled drug delivery features and methods of using same |
17 Oct, 2030
(5 years from now)
| Active |
| US12201557 | Drug eluting ocular implant and method of treating an ocular disorder |
18 Jun, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Idose Tr's drug page